Does lower doses of isoflurane treatment have no beneficial effects in a rat model of intracerebral hemorrhage?
Our data suggested that there is no neuroprotection after isoflurane posttreatment in a rat model of ICH.
PBD of malignant obstruction achieves clinically relevant reduction in serum bilirubin in the majority of patients within 1-2 months, irrespective of the pre-drainage serum bilirubin, sufficient to allow administration of systemic chemotherapy. However, the decision to undergo this procedure for this indication alone must be considered in the context of patients' prognosis and treatment goals.